| Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
|---|
| C026114 |
2-xylene |
2-xylene results in increased expression of NCF2 mRNA | increases expression | 20359517
|
| C056165 |
acetovanillone |
acetovanillone inhibits the reaction [LEP protein results in increased expression of NCF2 protein] | decreases reaction|increases expression | 16380530
|
| D000171 |
Acrolein |
Acrolein inhibits the reaction [Tetradecanoylphorbol Acetate affects the localization of NCF2 protein] | affects localization|decreases reaction | 11246141
|
| D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of NCF2 protein | affects expression | 20106945
|
| D016718 |
Arachidonic Acid |
Arachidonic Acid affects the reaction [Zymosan analog affects the localization of NCF2 protein] | affects localization|affects reaction | 12101222
|
| C006632 |
arsenic trioxide |
arsenic trioxide results in increased expression of NCF2 protein | increases expression | 15070760
|
| C015001 |
arsenite |
arsenite results in increased expression of NCF2 mRNA | increases expression | 18929588
|
| C015001 |
arsenite |
TRP53 protein affects the reaction [arsenite results in increased expression of NCF2 mRNA] | affects reaction|increases expression | 18929588
|
| D001554 |
Benzene |
Benzene results in increased expression of NCF2 mRNA | increases expression | 20359517
|
| D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in increased expression of NCF2 mRNA | increases expression | 20106945
|
| C006780 |
bisphenol A |
bisphenol A results in increased expression of NCF2 mRNA | increases expression | 14555285
|
| C086539 |
BQ 788 |
BQ 788 inhibits the reaction [LEP protein results in increased expression of NCF2 protein] | decreases reaction|increases expression | 16380530
|
| D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride results in increased expression of NCF2 mRNA | increases expression | 17854599
|
| D016572 |
Cyclosporine |
Cyclosporine results in increased expression of NCF2 mRNA | increases expression | 20106945
|
| C072247 |
cyclo(Trp-Asp-Pro-Val-Leu) |
cyclo(Trp-Asp-Pro-Val-Leu) inhibits the reaction [LEP protein results in increased expression of NCF2 protein] | decreases reaction|increases expression | 16380530
|
| D004958 |
Estradiol |
Estradiol affects the expression of NCF2 mRNA | affects expression | 14699072
|
| D004958 |
Estradiol |
Estradiol results in increased expression of NCF2 mRNA | increases expression | 20106945
|
| D004958 |
Estradiol |
Estradiol affects the expression of NCF2 mRNA | affects expression | 16195479
|
| D004958 |
Estradiol |
Estradiol inhibits the reaction [Progesterone results in increased expression of NCF2 mRNA] | decreases reaction|increases expression | 16195479
|
| D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of NCF2 mRNA | increases expression | 17942748
|
| D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of NCF2 mRNA | affects cotreatment|increases expression | 17942748
|
| C004912 |
ethylbenzene |
ethylbenzene results in increased expression of NCF2 mRNA | increases expression | 20359517
|
| D017313 |
Fenretinide |
Fenretinide results in increased expression of NCF2 protein | increases expression | 16077929 15059897
|
| D008752 |
Methylene Chloride |
Methylene Chloride results in increased expression of NCF2 mRNA | increases expression | 20359517
|
| C052753 |
nebivolol |
nebivolol inhibits the reaction [AGT protein affects the localization of NCF2 protein] | affects localization|decreases reaction | 16940222
|
| C052753 |
nebivolol |
nebivolol inhibits the reaction [AGT protein results in increased expression of NCF2 protein] | decreases reaction|increases expression | 16940222
|
| D019787 |
Linoleic Acid |
Linoleic Acid affects the reaction [Zymosan analog affects the localization of NCF2 protein] | affects localization|affects reaction | 12101222
|
| D010269 |
Paraquat |
Paraquat affects the localization of NCF2 protein | affects localization | 17662968
|
| D010269 |
Paraquat |
rottlerin inhibits the reaction [Paraquat affects the localization of NCF2 protein] | affects localization|decreases reaction | 17662968
|
| D052638 |
Particulate Matter |
NCF2 protein affects the reaction [Particulate Matter results in increased expression of IL6 mRNA] | affects reaction|increases expression | 19371610
|
| D052638 |
Particulate Matter |
NCF2 protein affects the reaction [Particulate Matter results in increased phosphorylation of MAPK1 protein] | affects reaction|increases phosphorylation | 19371610
|
| D052638 |
Particulate Matter |
NCF2 protein affects the reaction [Particulate Matter results in increased phosphorylation of MAPK3 protein] | affects reaction|increases phosphorylation | 19371610
|
| D052638 |
Particulate Matter |
NCF2 protein affects the susceptibility to Particulate Matter | affects response to substance | 19371610
|
| D052638 |
Particulate Matter |
Particulate Matter affects the localization of NCF2 protein | affects localization | 19371610
|
| D011374 |
Progesterone |
Estradiol inhibits the reaction [Progesterone results in increased expression of NCF2 mRNA] | decreases reaction|increases expression | 16195479
|
| D011374 |
Progesterone |
Progesterone results in increased expression of NCF2 mRNA | increases expression | 16195479
|
| D020849 |
Raloxifene |
ESR2 protein affects the reaction [Raloxifene results in decreased expression of NCF2 mRNA] | affects reaction|decreases expression | 14699072
|
| D020849 |
Raloxifene |
Raloxifene affects the expression of NCF2 mRNA | affects expression | 14699072
|
| D020849 |
Raloxifene |
[Raloxifene co-treated with ESR2 protein] results in decreased expression of NCF2 mRNA | affects cotreatment|decreases expression | 19059307
|
| C089730 |
rosiglitazone |
rosiglitazone results in decreased expression of NCF2 mRNA | decreases expression | 17255338
|
| C089730 |
rosiglitazone |
rosiglitazone results in decreased expression of NCF2 protein | decreases expression | 17255338
|
| C085746 |
rottlerin |
rottlerin inhibits the reaction [Paraquat affects the localization of NCF2 protein] | affects localization|decreases reaction | 17662968
|
| C017947 |
sodium arsenite |
sodium arsenite results in increased phosphorylation of NCF2 protein | increases phosphorylation | 19414066
|
| D013629 |
Tamoxifen |
Tamoxifen affects the expression of NCF2 mRNA | affects expression | 14699072
|
| D013629 |
Tamoxifen |
[Tamoxifen co-treated with ESR2 protein] results in decreased expression of NCF2 mRNA | affects cotreatment|decreases expression | 19059307
|
| D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of NCF2 mRNA | increases expression | 20106945
|
| D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of NCF2 mRNA | affects cotreatment|increases expression | 17942748
|
| D013755 |
Tetradecanoylphorbol Acetate |
Acrolein inhibits the reaction [Tetradecanoylphorbol Acetate affects the localization of NCF2 protein] | affects localization|decreases reaction | 11246141
|
| D013755 |
Tetradecanoylphorbol Acetate |
Tetradecanoylphorbol Acetate affects the localization of NCF2 protein | affects localization | 11246141
|
| D014050 |
Toluene |
Toluene results in increased expression of NCF2 mRNA | increases expression | 20359517
|
| D014212 |
Tretinoin |
Tretinoin results in increased expression of NCF2 mRNA | increases expression | 16249480
|
| D014241 |
Trichloroethylene |
Trichloroethylene results in increased expression of NCF2 mRNA | increases expression | 20359517
|
| C030665 |
triphenyltin |
triphenyltin results in increased expression of NCF2 mRNA | increases expression | 12788061
|
| D015054 |
Zymosan |
Arachidonic Acid affects the reaction [Zymosan analog affects the localization of NCF2 protein] | affects localization|affects reaction | 12101222
|
| D015054 |
Zymosan |
Linoleic Acid affects the reaction [Zymosan analog affects the localization of NCF2 protein] | affects localization|affects reaction | 12101222
|
| D015054 |
Zymosan |
NCF1 protein promotes the reaction [Zymosan analog affects the localization of NCF2 protein] | affects localization|increases reaction | 12101222
|
| D015054 |
Zymosan |
PLA2G4A protein promotes the reaction [Zymosan analog affects the localization of NCF2 protein] | affects localization|increases reaction | 12101222
|
| D015054 |
Zymosan |
Zymosan analog affects the localization of NCF2 protein | affects localization | 12101222
|
| D015054 |
Zymosan |
Zymosan analog promotes the reaction [NCF1 protein binds to NCF2 protein] | affects binding|increases reaction | 12101222
|
| D015054 |
Zymosan |
Zymosan analog results in increased phosphorylation of NCF2 protein | increases phosphorylation | 12101222
|
| Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
|---|
| MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
4.17 | 14745880 |
| MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.49 | 15322242 11752688 14514962 |
| MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
3.57 | 17505938 |
| MESH:D055371 |
Acute Lung Injury |
|
Acrolein |
8.93 | 21297076 20525806 |
| MESH:D055371 |
Acute Lung Injury |
|
Particulate Matter |
8.93 | 12396868 |
| MESH:D000230 |
Adenocarcinoma |
|
arsenic trioxide |
12.43 | 11798837 19825857 |
| MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
12.43 | 20127859 20464547 |
| MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
12.43 | 11473722 |
| MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
12.43 | 14692618 |
| MESH:D000230 |
Adenocarcinoma |
|
Fenretinide |
12.43 | 10697514 |
| MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
2.44 | 6695378 |
| MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.01 | 16835633 |
| MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.32 | 15276417 |
| MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
4.53 | 16712894 17306315 |
| MESH:D000382 |
Agricultural Workers' Diseases |
|
Paraquat |
3.40 | 11874814 |
| MESH:D000419 |
Albuminuria |
|
Raloxifene |
4.25 | 17451421 17308373 |
| MESH:D000505 |
Alopecia |
|
Tretinoin |
3.33 | 15955085 |
| MESH:D000544 |
Alzheimer Disease |
|
Acrolein |
8.81 | 17570602 15207723 14715435 |
| MESH:D000544 |
Alzheimer Disease |
|
Particulate Matter |
8.81 | 15513908 |
| MESH:D000544 |
Alzheimer Disease |
|
Raloxifene |
8.81 | 15800139 |
| MESH:D000544 |
Alzheimer Disease |
|
rosiglitazone |
8.81 | 19621015 |
| MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
7.94 | 11748828 |
| MESH:D000740 |
Anemia |
|
Zymosan |
7.94 | 18664788 |
| MESH:D000741 |
Anemia, Aplastic |
|
Benzene |
4.09 | 17661222 14761424 11369114 |
| MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
3.71 | 19183758 |
| MESH:D001161 |
Arteriosclerosis |
|
Acrolein |
9.13 | 15014928 |
| MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
9.13 | 11256880 |
| MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
11.03 | 15885639 |
| MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
11.03 | 16412693 |
| MESH:D001169 |
Arthritis, Experimental |
|
Zymosan |
11.03 | 15142272 17659584 15944321 16872482 15188379 |
| MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.17 | 16292516 |
| MESH:D001249 |
Asthma |
|
Tretinoin |
2.23 | 16456186 |
| MESH:D050197 |
Atherosclerosis |
|
Acrolein |
3.76 | 16037261 17363696 16126721 |
| MESH:D001321 |
Autistic Disorder |
|
Arachidonic Acid |
3.04 | 18582451 |
| MESH:D001321 |
Autistic Disorder |
|
Linoleic Acid |
3.04 | 18582451 |
| MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.05 | 16935849 |
| MESH:D001778 |
Blood Coagulation Disorders |
|
arsenic trioxide |
13.44 | 16206674 |
| MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
13.44 | 12125929 |
| MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
13.44 | 16206674 16197459 |
| MESH:D001836 |
Body Weight Changes |
|
2-xylene |
10.85 | 7457028 |
| MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
10.85 | 15340226 |
| MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.53 | 15746008 |
| MESH:D001855 |
Bone Marrow Diseases |
|
Benzene |
4.86 | 16183116 |
| MESH:D001862 |
Bone Resorption |
|
bisphenol A |
3.54 | 11985600 |
| MESH:D020201 |
Brain Hemorrhage, Traumatic |
|
Progesterone |
4.96 | 17868700 |
| MESH:D001930 |
Brain Injuries |
|
Progesterone |
9.77 | 15665606 15380490 15845082 |
| MESH:D001930 |
Brain Injuries |
|
Raloxifene |
9.77 | 16580743 |
| MESH:D001932 |
Brain Neoplasms |
|
Fenretinide |
4.04 | 16187019 |
| MESH:D001943 |
Breast Neoplasms |
|
Benzene |
9.13 | 17162533 11921183 |
| MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
9.13 | 20146248 17474063 |
| MESH:D001943 |
Breast Neoplasms |
|
bisphenol A |
9.13 | 17123778 |
| MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
9.13 | 17018787 12948864 17289903 18497071 17261762 16675129 14630087 19861407 |
| MESH:D001943 |
Breast Neoplasms |
|
Fenretinide |
9.13 | 16601279 |
| MESH:D001943 |
Breast Neoplasms |
|
Methylene Chloride |
9.13 | 15986119 |
| MESH:D001943 |
Breast Neoplasms |
|
Progesterone |
9.13 | 16175315 15562024 17614352 |
| MESH:D001943 |
Breast Neoplasms |
|
Raloxifene |
9.13 | 17952589 15758505 17440819 16912660 15572757 17893378 17595753 17049068 17261762 16837676 17242785 15775269 |
| MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
9.13 | 20005174 19142967 18984771 16202921 17440819 17893378 20859285 19221464 18425577 19189210 19059307 11161223 19288272 19487384 19289846 19011961 16818667 21138602 19244106 19410462 21152245 15565566 18997820 17261762 19200415 18351453 20065188 19115204 18629630 20544844 19103187 17049068 17242785 18855134 16873071 19189212 19155303 18815881 18821012 20135344 16273361 19084267 19066611 15668708 20390343 |
| MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
9.13 | 20435547 |
| MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
9.13 | 16873071 16166294 16443354 |
| MESH:D001943 |
Breast Neoplasms |
|
Trichloroethylene |
9.13 | 15986119 |
| MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.22 | 16813970 |
| MESH:D002051 |
Burkitt Lymphoma |
|
arsenic trioxide |
3.99 | 11589617 |
| MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.09 | 16111702 |
| MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Carbon Tetrachloride |
3.42 | 18705752 10355542 16011737 15700767 16050911 15721981 3786805 15673190 16192424 16227642 16097048 16124888 |
| MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.51 | 16835633 |
| MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.15 | 19066611 |
| MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
4.78 | 16168501 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
15.72 | 12619106 12907637 21507988 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
arsenic trioxide |
15.72 | 15553829 15073043 16217749 11135700 14691202 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Carbon Tetrachloride |
15.72 | 18788625 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
15.72 | 16924424 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Fenretinide |
15.72 | 16270382 17159502 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
15.72 | 17306315 16507464 15276417 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
15.72 | 16924424 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
15.72 | 1917145 |
| MESH:D002278 |
Carcinoma in Situ |
|
bisphenol A |
4.62 | 17123778 |
| MESH:D002291 |
Carcinoma, Papillary |
|
arsenic trioxide |
4.50 | 19014326 |
| MESH:D018288 |
Carcinoma, Small Cell |
|
arsenic trioxide |
3.80 | 12490120 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
13.09 | 20419170 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
Fenretinide |
13.09 | 16274795 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
13.09 | 18572023 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tetradecanoylphorbol Acetate |
13.09 | 18922899 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
13.09 | 16096774 16051514 |
| MESH:D002295 |
Carcinoma, Transitional Cell |
|
Raloxifene |
8.44 | 17572228 |
| MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
8.44 | 17572228 |
| MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.16 | 16120746 18670907 18850075 |
| MESH:D002318 |
Cardiovascular Diseases |
|
Particulate Matter |
7.16 | 12396868 |
| MESH:D002318 |
Cardiovascular Diseases |
|
Raloxifene |
7.16 | 15775269 |
| MESH:D002386 |
Cataract |
|
Tretinoin |
2.88 | 17460283 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
9.70 | 12371664 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
9.70 | 18566989 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
9.70 | 20056578 19524636 |
| MESH:D002547 |
Cerebral Palsy |
|
Toluene |
5.48 | 9294310 |
| MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Fenretinide |
11.75 | 16154183 |
| MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
11.75 | 16129372 |
| MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
2.85 | 16835633 |
| MESH:D002779 |
Cholestasis |
|
Cyclosporine |
6.88 | 19486331 |
| MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
6.88 | 16919318 15861022 11677210 17110522 16105132 17333356 17681005 |
| MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
4.78 | 16461808 |
| MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
5.23 | 12621046 8697196 16354765 15340226 15668235 |
| MESH:D002972 |
Cleft Palate |
|
Tretinoin |
5.23 | 9407595 |
| MESH:D003072 |
Cognition Disorders |
|
Raloxifene |
4.26 | 15800139 |
| MESH:D003092 |
Colitis |
|
Tretinoin |
3.35 | 17035595 |
| MESH:D003110 |
Colonic Neoplasms |
|
arsenite |
2.52 | 15037631 |
| MESH:D015179 |
Colorectal Neoplasms |
|
Acrolein |
3.46 | 17597105 |
| MESH:D015179 |
Colorectal Neoplasms |
|
arsenic trioxide |
3.46 | 20501625 |
| MESH:D015179 |
Colorectal Neoplasms |
|
Fenretinide |
3.46 | 17273769 |
| MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.75 | 17141729 14669216 |
| MESH:D023903 |
Coronary Restenosis |
|
arsenic trioxide |
3.84 | 12609071 |
| MESH:D019465 |
Craniofacial Abnormalities |
|
arsenic trioxide |
6.84 | 10525206 |
| MESH:D019465 |
Craniofacial Abnormalities |
|
Benzene |
6.84 | 15643154 |
| MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
6.84 | 15322242 10048152 20055451 |
| MESH:D019465 |
Craniofacial Abnormalities |
|
Toluene |
6.84 | 9294310 |
| MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
6.84 | 8800419 16925845 14991402 10589399 9224671 17551590 9142499 9211117 9664655 9125849 |
| MESH:D003556 |
Cystitis |
|
Acrolein |
5.02 | 12161096 |
| MESH:D003643 |
Death |
|
Toluene |
5.29 | 6431079 |
| MESH:D016757 |
Death, Sudden, Cardiac |
|
arsenic trioxide |
3.76 | 15213294 |
| MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
4.00 | 19031437 |
| MESH:D003865 |
Depressive Disorder, Major |
|
Raloxifene |
3.85 | 17474826 |
| MESH:D003872 |
Dermatitis |
|
Benzene |
4.41 | 15902427 |
| MESH:D003920 |
Diabetes Mellitus |
|
rosiglitazone |
3.99 | 17446233 |
| MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
rosiglitazone |
4.16 | 12642470 |
| MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
4.16 | 17107852 |
| MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
13.24 | 19279558 |
| MESH:D003928 |
Diabetic Nephropathies |
|
Raloxifene |
13.24 | 17308373 17451421 15920148 |
| MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
13.24 | 19279558 |
| MESH:D003929 |
Diabetic Neuropathies |
|
Progesterone |
4.13 | 17187935 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbon Tetrachloride |
5.66 | 7440962 6623471 19336974 3786805 17522070 10915739 4309450 7179309 3732212 15998439 2869522 6884620 9327722 10092053 16177239 21278145 15968718 7120509 16227642 11566570 19085960 15027814 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
5.66 | 20420201 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Trichloroethylene |
5.66 | 7120509 |
| MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.49 | 11462148 |
| MESH:D004487 |
Edema |
|
Arachidonic Acid |
22.83 | 7990266 15177302 9599246 11698051 16716910 9831321 |
| MESH:D004487 |
Edema |
|
Raloxifene |
22.83 | 15860553 |
| MESH:D004487 |
Edema |
|
rosiglitazone |
22.83 | 12083418 |
| MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
22.83 | 12711302 11000095 |
| MESH:D004487 |
Edema |
|
Tetradecanoylphorbol Acetate |
22.83 | 15177302 7812673 8273558 9599246 16716910 11698051 8113982 |
| MESH:D004487 |
Edema |
|
Zymosan |
22.83 | 7907874 |
| MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
10.69 | 15322242 18230668 16714409 |
| MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
10.69 | 18230668 |
| MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
19.06 | 12538720 |
| MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Progesterone |
19.06 | 17692515 |
| MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Raloxifene |
19.06 | 15845917 |
| MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
19.06 | 19031437 |
| MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
11.02 | 19148513 11473722 18566989 |
| MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
11.02 | 19155303 16202921 20544844 17893378 |
| MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
11.02 | 16569247 |
| MESH:D004715 |
Endometriosis |
|
Progesterone |
7.87 | 16134523 |
| MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
7.87 | 9294722 10568697 |
| MESH:D004938 |
Esophageal Neoplasms |
|
arsenic trioxide |
4.09 | 12903497 |
| MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
4.09 | 16530937 |
| MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
7.93 | 11564622 |
| MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
7.93 | 16938888 9664655 |
| MESH:D005234 |
Fatty Liver |
|
arsenic trioxide |
37.59 | 15073043 |
| MESH:D005234 |
Fatty Liver |
|
arsenite |
37.59 | 18296743 |
| MESH:D005234 |
Fatty Liver |
|
Carbon Tetrachloride |
37.59 | 15959796 61145 12631006 17595544 16239168 12795759 19224547 16045604 |
| MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
37.59 | 19224547 |
| MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
37.59 | 15345470 |
| MESH:D005234 |
Fatty Liver |
|
Raloxifene |
37.59 | 17473493 |
| MESH:D005234 |
Fatty Liver |
|
rosiglitazone |
37.59 | 19196556 |
| MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
37.59 | 19224547 14986274 |
| MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
3.01 | 16709447 |
| MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.10 | 11858732 |
| MESH:D005334 |
Fever |
|
Arachidonic Acid |
4.34 | 11852909 |
| MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
4.16 | 14745880 |
| MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
3.81 | 19069698 |
| MESH:D005355 |
Fibrosis |
|
arsenite |
23.92 | 18296743 |
| MESH:D005355 |
Fibrosis |
|
Carbon Tetrachloride |
23.92 | 18705752 |
| MESH:D005355 |
Fibrosis |
|
Cyclosporine |
23.92 | 12168785 12639820 |
| MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
23.92 | 20067830 |
| MESH:D005355 |
Fibrosis |
|
Tretinoin |
23.92 | 17994277 |
| MESH:D005706 |
Gallbladder Neoplasms |
|
arsenic trioxide |
3.91 | 16904648 |
| MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.31 | 16452187 |
| MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
3.85 | 8708960 |
| MESH:D005909 |
Glioblastoma |
|
Fenretinide |
6.64 | 16187019 |
| MESH:D005909 |
Glioblastoma |
|
Tretinoin |
6.64 | 17312396 |
| MESH:D005911 |
Gliosis |
|
Paraquat |
4.79 | 11124998 |
| MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.22 | 10696789 |
| OMIM:233710 |
GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE, TYPE II |
marker/mechanism |
|
| |
| MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
2.94 | 16096774 |
| MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
4.78 | 16084493 |
| MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
9.94 | 20471113 |
| MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
9.94 | 10048152 11294989 |
| MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
9.94 | 14991402 9664655 |
| MESH:D006331 |
Heart Diseases |
|
Raloxifene |
3.28 | 11110106 |
| MESH:D006402 |
Hematologic Diseases |
|
Benzene |
4.32 | 16183116 |
| MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.05 | 15720958 |
| MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.01 | 11000095 |
| MESH:D006505 |
Hepatitis |
|
Carbon Tetrachloride |
8.50 | 19900420 19110552 |
| MESH:D006505 |
Hepatitis |
|
Zymosan |
8.50 | 19110552 |
| MESH:D006529 |
Hepatomegaly |
|
2-xylene |
7.82 | 7457028 7457013 |
| MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
7.82 | 15340226 12621046 16120746 |
| MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.66 | 15709030 |
| MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
2.85 | 12676792 |
| MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.38 | 17088409 |
| MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.67 | 8697196 16959395 15340226 16354765 18606429 |
| MESH:D006930 |
Hyperalgesia |
|
rosiglitazone |
7.12 | 12083418 |
| MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
7.12 | 16870215 |
| MESH:D006932 |
Hyperbilirubinemia |
|
Carbon Tetrachloride |
4.16 | 16899240 |
| MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.21 | 16778211 |
| MESH:D006943 |
Hyperglycemia |
|
triphenyltin |
5.35 | 10522495 |
| MESH:D006973 |
Hypertension |
|
Benzene |
11.16 | 17940673 |
| MESH:D006973 |
Hypertension |
|
Cyclosporine |
11.16 | 10903974 |
| MESH:D006973 |
Hypertension |
|
Raloxifene |
11.16 | 15787275 17577099 |
| MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
11.16 | 18670907 18850075 |
| MESH:D006975 |
Hypertension, Portal |
|
Carbon Tetrachloride |
3.73 | 15338365 |
| MESH:D006976 |
Hypertension, Pulmonary |
|
cyclo(Trp-Asp-Pro-Val-Leu) |
4.93 | 16327149 |
| MESH:D015228 |
Hypertriglyceridemia |
|
triphenyltin |
5.64 | 10522495 |
| MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.45 | 16569931 16945680 |
| MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
Progesterone |
4.04 | 15869954 |
| MESH:D007246 |
Infertility |
|
triphenyltin |
5.67 | 15205045 |
| MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.12 | 12013081 |
| MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
9.81 | 17937319 |
| MESH:D007248 |
Infertility, Male |
|
Paraquat |
9.81 | 4850670 |
| MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
9.81 | 12646999 15346721 |
| MESH:D007249 |
Inflammation |
|
Arachidonic Acid |
21.22 | 15177302 9831321 17371808 |
| MESH:D007249 |
Inflammation |
|
Progesterone |
21.22 | 15869954 |
| MESH:D007249 |
Inflammation |
|
rosiglitazone |
21.22 | 12083418 |
| MESH:D007249 |
Inflammation |
|
Tamoxifen |
21.22 | 19457130 |
| MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
21.22 | 12878042 12200463 |
| MESH:D007249 |
Inflammation |
|
Tetradecanoylphorbol Acetate |
21.22 | 11698051 8273558 15177302 7812673 7562506 |
| MESH:D007249 |
Inflammation |
|
Zymosan |
21.22 | 11289658 8014878 |
| MESH:D007333 |
Insulin Resistance |
|
bisphenol A |
11.07 | 16393666 |
| MESH:D007333 |
Insulin Resistance |
|
Estradiol |
11.07 | 16393666 16627594 |
| MESH:D007333 |
Insulin Resistance |
|
rosiglitazone |
11.07 | 16306350 |
| MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.41 | 17994277 |
| MESH:D043183 |
Irritable Bowel Syndrome |
|
Zymosan |
5.47 | 17553498 |
| MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
8.84 | 16580747 |
| MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
8.84 | 15992940 17551590 |
| MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.07 | 15604871 |
| MESH:D007674 |
Kidney Diseases |
|
Acrolein |
12.72 | 12488133 |
| MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
12.72 | 8314463 10903974 18776723 |
| MESH:D007674 |
Kidney Diseases |
|
Estradiol |
12.72 | 15618244 |
| MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
12.72 | 20008137 |
| MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
10.66 | 12371664 |
| MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
10.66 | 15610895 |
| MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
10.66 | 18625569 |
| MESH:D007889 |
Leiomyoma |
|
Raloxifene |
4.16 | 16973256 |
| MESH:D007938 |
Leukemia |
|
arsenic trioxide |
9.45 | 15070760 |
| MESH:D007938 |
Leukemia |
|
Benzene |
9.45 | 18335105 17119257 14694614 15935818 |
| MESH:D007938 |
Leukemia |
|
Tretinoin |
9.45 | 17143497 |
| MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
arsenic trioxide |
3.47 | 12560223 17077332 |
| MESH:D007948 |
Leukemia, Monocytic, Acute |
|
arsenic trioxide |
3.94 | 16972261 |
| MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
arsenic trioxide |
3.16 | 14633726 |
| MESH:D007951 |
Leukemia, Myeloid |
|
arsenic trioxide |
14.14 | 19077051 |
| MESH:D007951 |
Leukemia, Myeloid |
|
Benzene |
14.14 | 17506065 |
| MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
14.14 | 16932348 16482212 19285840 |
| MESH:D015470 |
Leukemia, Myeloid, Acute |
|
arsenic trioxide |
5.73 | 16467208 19850784 20471514 16968895 17050201 |
| MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Benzene |
5.73 | 19478238 |
| MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
5.73 | 19850784 16294345 17596541 |
| MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
arsenic trioxide |
6.83 | 16966277 17712046 15748426 17107899 19225113 15213294 19035177 12712474 15336539 16112521 12018890 16891316 16331271 17869043 17217047 19075265 15622746 12679006 19642359 17649720 16330433 11468182 9834237 11161223 16823087 |
| MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
6.83 | 15748426 9834237 16140955 19075265 17301526 17649720 17217047 17339181 17368321 19642359 16766008 16891316 16935935 19029980 16331271 17107899 12679006 19225113 17506722 16788101 17712046 17294898 17361223 16823087 19035177 |
| MESH:D015458 |
Leukemia, T-Cell |
|
arsenic trioxide |
4.00 | 16882451 |
| MESH:D007972 |
Leukoplakia, Oral |
|
Fenretinide |
5.67 | 16707609 |
| MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.05 | 9224671 |
| MESH:D008064 |
Lipidoses |
|
Tamoxifen |
2.89 | 17567588 15342952 |
| MESH:D008103 |
Liver Cirrhosis |
|
arsenite |
6.14 | 18296743 |
| MESH:D008103 |
Liver Cirrhosis |
|
Carbon Tetrachloride |
6.14 | 16221502 11408273 17334410 17174718 17157831 16943688 11903743 21278145 16239168 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Carbon Tetrachloride |
8.04 | 18395914 18251166 16027843 16248980 16192424 15370692 18205269 14512876 12741479 18472094 17631135 17823541 17525996 14748882 17640975 12666154 15996030 16136751 16116963 15730626 15052691 18376398 17766677 16015684 18481824 17714472 16097048 17976157 11481614 12445418 18418968 15673190 12586293 12649538 18412020 15959796 15362042 18277467 16033810 18472332 15893842 17481882 13678700 18054572 20821823 16638106 10355542 17922224 12667390 17761835 12958196 12389079 15818738 15338365 15650968 18210741 12632512 17698563 17944888 12632514 14724832 12609069 15057751 18395095 18156304 15925388 17721639 18420326 12546737 14620537 15123356 17869086 15876570 17805973 18429990 18006644 17565644 18263696 12898905 17708605 12445421 14716496 17900296 14716833 18339082 15931870 18279442 16011737 18166357 17557913 18317297 18187930 18705752 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
8.04 | 14716833 14659978 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
rosiglitazone |
8.04 | 15980055 17347453 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
8.04 | 18564211 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
8.04 | 12878042 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
8.04 | 18397230 16248980 |
| MESH:D008107 |
Liver Diseases |
|
Carbon Tetrachloride |
1.99 | 16246199 15720792 17285989 15830285 16964402 |
| MESH:D017093 |
Liver Failure |
|
Carbon Tetrachloride |
3.80 | 15123358 |
| MESH:D017114 |
Liver Failure, Acute |
|
Carbon Tetrachloride |
3.37 | 16899240 14706259 |
| MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
19.61 | 2125692 18177683 9163691 15890375 |
| MESH:D008113 |
Liver Neoplasms |
|
arsenic trioxide |
19.61 | 14682389 |
| MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
19.61 | 20195826 21137059 |
| MESH:D008113 |
Liver Neoplasms |
|
Carbon Tetrachloride |
19.61 | 19294768 |
| MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
19.61 | 15276417 16712894 |
| MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
19.61 | 16684651 |
| MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
19.61 | 16984957 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
20.36 | 8603461 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
arsenic trioxide |
20.36 | 20377131 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
Benzene |
20.36 | 12562636 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
Carbon Tetrachloride |
20.36 | 12014681 15583823 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
20.36 | 12151625 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
Trichloroethylene |
20.36 | 7955063 |
| MESH:D008133 |
Long QT Syndrome |
|
arsenic trioxide |
3.07 | 15213294 |
| MESH:D008171 |
Lung Diseases |
|
Acrolein |
7.00 | 11504702 |
| MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
7.00 | 19095001 |
| MESH:D017563 |
Lung Diseases, Interstitial |
|
Benzene |
4.43 | 14698565 |
| MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
16.78 | 14755239 |
| MESH:D008175 |
Lung Neoplasms |
|
arsenic trioxide |
16.78 | 11798837 19825857 |
| MESH:D008175 |
Lung Neoplasms |
|
arsenite |
16.78 | 16809336 |
| MESH:D008175 |
Lung Neoplasms |
|
Benzene |
16.78 | 12562636 |
| MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
16.78 | 17053015 18569708 20064080 18816296 6695378 20464547 18520028 20135361 20869020 |
| MESH:D008175 |
Lung Neoplasms |
|
Methylene Chloride |
16.78 | 15172992 |
| MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
16.78 | 17306315 15276417 16712894 19931552 17077188 |
| MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
16.78 | 18625569 |
| MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
16.78 | 19555203 11884234 |
| MESH:D008175 |
Lung Neoplasms |
|
Tetradecanoylphorbol Acetate |
16.78 | 11807781 |
| MESH:D008223 |
Lymphoma |
|
Benzene |
3.48 | 17584886 17119257 |
| MESH:D015674 |
Mammary Neoplasms, Animal |
|
Benzene |
8.85 | 12562636 |
| MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
8.85 | 19428831 |
| MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Benzene |
24.86 | 11921183 |
| MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
24.86 | 11408345 11807958 16891317 17203775 |
| MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Fenretinide |
24.86 | 10697514 |
| MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Progesterone |
24.86 | 17203775 11408345 |
| MESH:D008325 |
Mammary Neoplasms, Experimental |
|
rosiglitazone |
24.86 | 16827153 |
| MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
24.86 | 14580682 19196722 11731420 19196723 16827153 |
| MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tetradecanoylphorbol Acetate |
24.86 | 8985016 |
| MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
11.40 | 19453300 |
| MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
11.40 | 19453300 |
| MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.63 | 17453147 |
| MESH:D008545 |
Melanoma |
|
Fenretinide |
6.71 | 16270382 |
| MESH:D008545 |
Melanoma |
|
sodium arsenite |
6.71 | 16487513 19082730 |
| MESH:D008545 |
Melanoma |
|
Tamoxifen |
6.71 | 19393235 12393984 |
| MESH:D008545 |
Melanoma |
|
Tretinoin |
6.71 | 16752155 |
| MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
3.81 | 15990972 |
| MESH:D008546 |
Melanoma, Experimental |
|
Acrolein |
4.85 | 10803710 |
| MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.06 | 16940565 |
| MESH:D008607 |
Mental Retardation |
|
Toluene |
3.52 | 9294310 |
| MESH:D024821 |
Metabolic Syndrome X |
|
rosiglitazone |
4.08 | 17261469 |
| MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.41 | 16801185 |
| MESH:D018200 |
Mixed Tumor, Mullerian |
|
Raloxifene |
5.18 | 15863610 |
| MESH:D019957 |
Motor Skills Disorders |
|
Toluene |
4.89 | 9294310 |
| MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
7.85 | 16381670 |
| MESH:D009062 |
Mouth Neoplasms |
|
Fenretinide |
7.85 | 16274795 |
| MESH:D009101 |
Multiple Myeloma |
|
arsenic trioxide |
10.70 | 19549372 19417148 11468182 15949261 14977855 |
| MESH:D009101 |
Multiple Myeloma |
|
Benzene |
10.70 | 17119195 |
| MESH:D009101 |
Multiple Myeloma |
|
Raloxifene |
10.70 | 16497877 |
| MESH:D009102 |
Multiple Organ Failure |
|
Zymosan |
4.87 | 12130978 15834315 15213630 10890648 10479408 12879239 18160304 15259001 15241586 17724436 |
| MESH:D009182 |
Mycosis Fungoides |
|
arsenic trioxide |
4.30 | 18349030 |
| MESH:D009190 |
Myelodysplastic Syndromes |
|
arsenic trioxide |
6.68 | 16105982 16882451 |
| MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
6.68 | 17596541 |
| MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.73 | 12213967 |
| MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
3.00 | 16810080 |
| MESH:D009205 |
Myocarditis |
|
Particulate Matter |
5.59 | 12563109 |
| MESH:D009232 |
Myxoma |
|
Raloxifene |
5.18 | 16343187 |
| MESH:D009361 |
Neoplasm Invasiveness |
|
arsenic trioxide |
3.61 | 16624393 |
| MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
2.40 | 19393235 |
| MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.39 | 19410462 |
| MESH:D009369 |
Neoplasms |
|
Acrolein |
17.36 | 17329238 |
| MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
17.36 | 11141357 |
| MESH:D009369 |
Neoplasms |
|
Fenretinide |
17.36 | 15958647 17353921 |
| MESH:D009369 |
Neoplasms |
|
sodium arsenite |
17.36 | 11559025 |
| MESH:D009369 |
Neoplasms |
|
Tretinoin |
17.36 | 16946489 16594593 |
| MESH:D009369 |
Neoplasms |
|
Trichloroethylene |
17.36 | 11911487 |
| MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
3.31 | 20056578 |
| MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
3.63 | 19196722 19189210 19200415 |
| MESH:D009389 |
Neovascularization, Pathologic |
|
arsenite |
8.93 | 15738583 |
| MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
8.93 | 17289903 |
| MESH:D009393 |
Nephritis |
|
Acrolein |
5.91 | 12653641 |
| MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.07 | 17954296 |
| MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
2.98 | 18481113 19348381 |
| MESH:D009410 |
Nerve Degeneration |
|
Paraquat |
3.44 | 16893418 |
| MESH:D009421 |
Nervous System Malformations |
|
bisphenol A |
20.56 | 16427766 11399458 |
| MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
20.56 | 11399458 16427766 |
| MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
20.56 | 14600291 |
| MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
20.56 | 9125849 |
| MESH:D009436 |
Neural Tube Defects |
|
arsenic trioxide |
15.38 | 10525206 |
| MESH:D009436 |
Neural Tube Defects |
|
Benzene |
15.38 | 15643154 |
| MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
15.38 | 12854658 |
| MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
15.38 | 9142499 |
| MESH:D019636 |
Neurodegenerative Diseases |
|
Acrolein |
4.22 | 11342003 |
| MESH:D009472 |
Neuronal Ceroid-Lipofuscinoses |
|
Fenretinide |
5.31 | 16303764 |
| MESH:D009784 |
Occupational Diseases |
|
Benzene |
3.86 | 15913788 17119257 15935809 15612468 15727169 17178637 16737584 15576619 17479406 |
| MESH:D010024 |
Osteoporosis |
|
Raloxifene |
3.17 | 17882678 19059307 15775268 |
| MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Raloxifene |
3.89 | 15758505 15579764 17893378 17823083 |
| MESH:D010049 |
Ovarian Diseases |
|
bisphenol A |
4.62 | 11985600 |
| MESH:D010051 |
Ovarian Neoplasms |
|
arsenic trioxide |
21.00 | 19769630 16624393 12452020 |
| MESH:D010051 |
Ovarian Neoplasms |
|
Benzene |
21.00 | 12562636 |
| MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
21.00 | 19401270 |
| MESH:D010051 |
Ovarian Neoplasms |
|
Fenretinide |
21.00 | 16133793 |
| MESH:D010051 |
Ovarian Neoplasms |
|
Progesterone |
21.00 | 17393432 16525653 |
| MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
21.00 | 17306315 15276417 |
| MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
21.00 | 16936753 |
| MESH:D010146 |
Pain |
|
Tretinoin |
2.62 | 16870215 |
| MESH:D010190 |
Pancreatic Neoplasms |
|
arsenic trioxide |
11.23 | 15580305 |
| MESH:D010190 |
Pancreatic Neoplasms |
|
Fenretinide |
11.23 | 15580305 |
| MESH:D010190 |
Pancreatic Neoplasms |
|
Tetradecanoylphorbol Acetate |
11.23 | 15976015 |
| MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
11.23 | 15976015 |
| MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.35 | 11578682 |
| MESH:D010212 |
Papilloma |
|
Tetradecanoylphorbol Acetate |
3.94 | 8330346 18922899 12065085 18404319 |
| MESH:D010235 |
Paraganglioma |
|
arsenic trioxide |
3.82 | 19927285 |
| MESH:D010300 |
Parkinson Disease |
|
Acrolein |
5.32 | 17690948 |
| MESH:D010300 |
Parkinson Disease |
|
Paraquat |
5.32 | 15451049 16140633 12911755 16510128 11124998 11181820 11445065 15824117 |
| MESH:D010302 |
Parkinson Disease, Secondary |
|
Paraquat |
4.07 | 16190885 |
| MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
3.87 | 12520081 |
| MESH:D010538 |
Peritonitis |
|
Zymosan |
4.52 | 17826846 14761945 18977430 19088179 17371808 19641140 18557954 15979727 18760300 11985352 15259001 |
| MESH:D010787 |
Photosensitivity Disorders |
|
Acrolein |
5.36 | 11550810 |
| MESH:D011014 |
Pneumonia |
|
Paraquat |
4.09 | 12504350 |
| MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.21 | 18163543 |
| MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
2.92 | 12371664 |
| MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
bisphenol A |
8.29 | 10548101 |
| MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
8.29 | 11896295 11399792 11118676 11222880 |
| MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
bisphenol A |
9.46 | 20887781 |
| MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
9.46 | 20887781 |
| MESH:D011471 |
Prostatic Neoplasms |
|
arsenic trioxide |
2.36 | 19131511 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
2.36 | 17292933 |
| MESH:D011471 |
Prostatic Neoplasms |
|
bisphenol A |
2.36 | 16740699 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
2.36 | 16740699 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Fenretinide |
2.36 | 17024972 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Raloxifene |
2.36 | 15731164 16536755 16220300 |
| MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
2.36 | 16039940 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
2.36 | 15067354 |
| MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.27 | 16636307 |
| MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
2.95 | 15861022 16919318 |
| MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.10 | 16882103 |
| MESH:D011625 |
Pterygium |
|
Tretinoin |
4.42 | 16723453 |
| MESH:D011629 |
Puberty, Precocious |
|
bisphenol A |
4.42 | 10548101 |
| MESH:D011658 |
Pulmonary Fibrosis |
|
Paraquat |
5.83 | 17997886 16324872 |
| MESH:D011658 |
Pulmonary Fibrosis |
|
Particulate Matter |
5.83 | 12475806 |
| MESH:D011693 |
Purpura |
|
Raloxifene |
5.18 | 15770314 |
| MESH:D051437 |
Renal Insufficiency |
|
Acrolein |
4.65 | 12732208 |
| MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Paraquat |
3.57 | 11700416 |
| MESH:D012135 |
Respiratory Sounds |
|
Paraquat |
3.70 | 11874814 |
| MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.49 | 18990726 |
| MESH:D012162 |
Retinal Degeneration |
|
Fenretinide |
8.38 | 16303925 |
| MESH:D012162 |
Retinal Degeneration |
|
Paraquat |
8.38 | 16458197 |
| MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
3.76 | 16116481 16283617 |
| MESH:D012468 |
Salivary Gland Neoplasms |
|
Progesterone |
2.72 | 18045962 |
| MESH:D012512 |
Sarcoma, Ewing's |
|
arsenic trioxide |
3.61 | 16646077 |
| MESH:D012640 |
Seizures |
|
Toluene |
3.48 | 6431079 9294310 |
| MESH:D018805 |
Sepsis |
|
Zymosan |
4.35 | 11441115 |
| MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
20.14 | 19755658 10029692 |
| MESH:D012878 |
Skin Neoplasms |
|
Fenretinide |
20.14 | 16467112 |
| MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
20.14 | 18572023 19524636 |
| MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
20.14 | 16192470 |
| MESH:D012878 |
Skin Neoplasms |
|
Tetradecanoylphorbol Acetate |
20.14 | 18404319 8985016 8330346 11807781 12065085 |
| MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
20.14 | 16467112 |
| MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
10.31 | 16709447 |
| MESH:D013088 |
Spermatocele |
|
Tamoxifen |
10.31 | 16709447 |
| MESH:D013119 |
Spinal Cord Injuries |
|
Progesterone |
9.65 | 16503802 15862959 |
| MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
9.65 | 19457130 |
| MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.51 | 12854658 |
| MESH:D013274 |
Stomach Neoplasms |
|
arsenic trioxide |
4.39 | 17007042 |
| MESH:D013274 |
Stomach Neoplasms |
|
Benzene |
4.39 | 12562636 |
| MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
4.39 | 2093021 20155912 |
| MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
4.39 | 17261132 |
| MESH:D020521 |
Stroke |
|
Acrolein |
8.13 | 16269634 |
| MESH:D020521 |
Stroke |
|
Raloxifene |
8.13 | 16837676 |
| MESH:D019966 |
Substance-Related Disorders |
|
bisphenol A |
3.62 | 16045194 16684133 |
| MESH:D013733 |
Testicular Diseases |
|
Toluene |
4.59 | 10514026 10048760 |
| MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.28 | 11994571 |
| MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
2.85 | 15669648 |
| MESH:D013953 |
Thymus Neoplasms |
|
Benzene |
4.59 | 10850423 |
| MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.53 | 12697716 |
| MESH:D013964 |
Thyroid Neoplasms |
|
arsenic trioxide |
6.29 | 19014326 |
| MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
6.29 | 17045167 16026305 |
| MESH:D013978 |
Tibial Fractures |
|
Estradiol |
12.46 | 19048282 |
| MESH:D013978 |
Tibial Fractures |
|
Raloxifene |
12.46 | 19048282 |
| MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
3.47 | 16051514 |
| MESH:D016171 |
Torsades de Pointes |
|
arsenic trioxide |
3.59 | 15213294 |
| MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.00 | 16040207 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
arsenic trioxide |
17.90 | 12973940 12845720 20435036 11780464 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
17.90 | 17053015 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
Fenretinide |
17.90 | 16720286 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
Raloxifene |
17.90 | 17572228 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
17.90 | 17306315 16452187 16712894 11723127 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
17.90 | 16712894 8653321 17572228 |
| MESH:D002583 |
Uterine Cervical Neoplasms |
|
Fenretinide |
14.11 | 16154183 |
| MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
14.11 | 11813266 |
| MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
14.11 | 16129372 |
| MESH:D014591 |
Uterine Diseases |
|
bisphenol A |
4.63 | 14652134 |
| MESH:D014594 |
Uterine Neoplasms |
|
Benzene |
8.41 | 12562636 |
| MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
8.41 | 14692618 |
| MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
4.24 | 16752155 |
| MESH:D014605 |
Uveitis |
|
Cyclosporine |
10.73 | 1336536 |
| MESH:D014605 |
Uveitis |
|
Zymosan |
10.73 | 11006244 |
| MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.06 | 17056641 |
| MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.22 | 12125929 |
| MESH:D054556 |
Venous Thromboembolism |
|
Raloxifene |
4.83 | 16837676 |
| MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.21 | 14671159 15869587 |
| MESH:D014820 |
Vitiligo |
|
Tretinoin |
3.71 | 16761959 |
| MESH:D014846 |
Vulvar Neoplasms |
|
Raloxifene |
5.18 | 16343187 |
| MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
3.87 | 15886252 |
| MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
3.66 | 16287080 |
| MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.07 | 17120751 |